CDKN2A and lung carcinoma: However, this has not been supported in studies where p16 is correlated with outcome, with some studies showing that p16 + cells on histology or p16 transcripts directly correlate with worse survival from lung cancer (Győrffy et al., 2013; Pezzuto et al., 2020).